MedPath

Vagus Nerve Stimulation Effects on Autonomic Nervous System Activity

Not Applicable
Completed
Conditions
Vagus Nerve Stimulation
Interventions
Device: Transcutaneous Auricular Vagus Nerve Stimulation
Registration Number
NCT06086236
Lead Sponsor
Bahçeşehir University
Brief Summary

Transcutaneous Auricular Vagus nerve stimulation may be successful in cardiac modulation because of the cardiac connections of the vagal nerve. Therefore, in order to observe the cardiac effects, it was analysed the changes in pulse rate, systolic and diastolic blood pressure after transcutaneous auricular vagus nerve stimulation application.

Detailed Description

Participants were divided into four groups (Figure 1) according to PNS and SNS indexes as Group 1 (PNS index \<-2, SNS index \>+2), Group 2 (PNS index \<-2, SNS index \<+2), Group 3 (PNS index \>-2, SNS index \>+2), Group 4 (PNS index \>-2, SNS index \<+2). Participants were assessed with blood pressure, pulse rate and HRV before and after taVNS stimulation. Sympathetic nervous system (SNS) index and parasympathetic nervous system (PNS) index values were assumed to be between -2 and +2 (95%) in the normal population according to Kubios software, and the grouping method was based on this situation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Age between 18 and 40 years old.
  • No previous vagus nerve stimulation
Exclusion Criteria
  • Using of any drug, alcohol or smoking.
  • Pregnancy.
  • Known history of acute or chronic illness.
  • Being in the post or peri-menopausal stage.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PNS Index<-2 and SNS Index<2Transcutaneous Auricular Vagus Nerve StimulationParticipants with Parasympathetic Nervous System (PNS) and Sympathetic Nervous System (SNS) Indexes values ''PNS\<-2, SNS\<2'' according to the results of heart rate variability measurements were included in this group. Then bilateral transcutaneous auricular vagus nerve stimulation was performed.
PNS Index>-2 and SNS Index>2Transcutaneous Auricular Vagus Nerve StimulationParticipants with Parasympathetic Nervous System (PNS) and Sympathetic Nervous System (SNS) Indexes values ''PNS\>-2, SNS\>2'' according to the results of heart rate variability measurements were included in this group. Then bilateral transcutaneous auricular vagus nerve stimulation was performed.
PNS Index<-2 and SNS Index>2Transcutaneous Auricular Vagus Nerve StimulationParticipants with Parasympathetic Nervous System (PNS) and Sympathetic Nervous System (SNS) Indexes values ''PNS\<-2, SNS\>2'' according to the results of heart rate variability measurements were included in this group. Then bilateral transcutaneous auricular vagus nerve stimulation was performed.
PNS Index>-2 and SNS Index<2Transcutaneous Auricular Vagus Nerve StimulationParticipants with Parasympathetic Nervous System (PNS) and Sympathetic Nervous System (SNS) Indexes values ''PNS\>-2, SNS\<2'' according to the results of heart rate variability measurements were included in this group. Then bilateral transcutaneous auricular vagus nerve stimulation was performed.
Primary Outcome Measures
NameTimeMethod
Systolic Blood PressureUp to 6 Months

The systolic blood pressure of the participants was measured with an electronic blood pressure monitor.

Diastolic Blood PressureUp to 6 Months

The diastolic blood pressure of the participants was measured with an electronic blood pressure monitor.

Pulse RateUp to 6 Months

The pulse rate of the participants was measured with an electronic blood pressure monitor.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Igdir University

🇹🇷

Iğdır, Merkez, Turkey

© Copyright 2025. All Rights Reserved by MedPath